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Abstract
Background: The human skin-derived precursors (SKPs) are a good cell source for regeneration. However, the
isolation of SKP from human skin is limited. To overcome this drawback, we hypothesized that the component of
plant stem cells could convert human fibroblasts to SKPs.
Methods: Human dermal fibroblasts were treated with shikimic acid, a major component of Sequoiadendron
giganteum callus extract. The characteristics of these reprogrammed cells were analyzed by qPCR, western blot,
colony-forming assay, and immunofluorescence staining. Artificial human skin was used for CO2 laser-induced
wound experiments. Human tissues were analyzed by immunohistochemistry.
Results: The reprogrammed cells expressed nestin (a neural precursor-specific protein), fibronectin, and vimentin
and could differentiate into the ectodermal and mesodermal lineage. Nestin expression was induced by shikimic
acid through the mannose receptor and subsequent MYD88 activation, leading to P38 phosphorylation and then
CREB binding to the nestin gene promoter. Finally, we confirmed that shikimic acid facilitated the healing of cut
injury and enhanced dermal reconstruction in a human artificial skin model. Moreover, in a clinical study with
healthy volunteers, plant callus extracts increased the expression of stem cell markers in the basal layer of the
epidermis and collagen deposit in the dermis.
Conclusions: These results indicate that shikimic acid is an effective agent for tissue regeneration.
Keywords: Shikimic acid, Cell reprogramming, Neural precursor, Skin-derived precursor, Single chemical-derived
trans-differentiation
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Introduction
We have recently demonstrated that the protein extract
from mouse embryonic stem cells (ESCs) or induced
pluripotent stem cells (iPSCs) has a potential to convert
mouse fibroblasts into iPSCs [1, 2]. Afterwards, we in-
vestigated whether human iPSCs could be generated by
treatment with human ESC extract; however, we were
unable to optimize the reprogramming method because
it required a large amount of human ESC protein extract
(20–50mg). It was not possible to repeatedly obtain this
amount per experiment because of the high expenditure
of the culture system and batch-to-batch variations. To
overcome these obstacles, we searched for a compound
that could generate stem/progenitor cells with multi-
potency and allow us to maintain them in an easy and
inexpensive way. Based on recent findings, we hypothe-
sized that plant callus extract could be the most appro-
priate candidate material for optimizing the process.
The formation of calluses in plants is induced by
strong activation of the meristem [3], which hosts plant
stem cells and is the ultimate source of all tissues in a
plant. Calluses are massive growth of cells and accumu-
lation of callose, a plant polysaccharide associated with
wounds. It can be produced from single undifferentiated
cells, which are totipotent, i.e., able to regenerate the
whole body of a plant. In plants, regeneration is trig-
gered by the loss of a tissue structure by injury, e.g., by
excision of the tip of a stem, leaf, or root. In response,
the plant callus acquires features similar to meristematic
cells and develops into new stem cells that are capable
of forming new individual plants [4]. Interestingly, the
extract of plant calluses can be used for effective treat-
ment of animal cells: a recent study showed that the ex-
tract of Swiss apple callus enhanced human stem cell
proliferation, prevented apoptosis of umbilical cord
blood stem cells from UV radiation, and reversed senes-
cence in fibroblasts, leading to a prolonged lifespan of
human skin cells [5].
The skin is a distinctive organ, because it has continu-
ous cyclic cell turnover and is capable of regeneration to
repair intrinsic and extrinsic injuries. This capacity nor-
mally originates from somatic tissue stem cells, such as
mesenchymal stem cells in the epidermal basal layer,
melanocyte stem cells, dermal stem cells, and hair folli-
cles [6]. Dermal stem cells are responsible for maintain-
ing homeostatic integrity and regeneration of the
dermis. Skin-derived precursor cells (SKPCs) were suc-
cessfully separated from adult skin in a trial to isolate
neural precursor cells from the skin [7]. The characteris-
tics of SKPCs are nearly identical to those of neural pre-
cursor cells (NPCs) [8]: they express not only vimentin,
a type III intermediate filamentous protein that is
expressed in mesenchymal cells, but also nestin, a type
VI intermediate filament that is mostly expressed in the
neural cell lineage. Moreover, SKPCs showed multipo-
tency, namely differentiation into mesodermal and per-
ipheral neural progeny [9]. They can be obtained from
primary culture of skin biopsy samples from subjects, re-
gardless of their age, site of biopsy, or disease [10]. It has
recently been reported they can also differentiate into
insulin-producing cells [11]. Since their first discovery,
they have been extensively studied, and there are prom-
ising results regarding their use in regenerative and cell
therapy. However, the isolation of SKPCs using the
existing protocol that includes isolation from human
skin has low efficiency and faces technical difficulties
[12]. Therefore, we aimed to establish conditions for de-
riving SKPCs from human dermal fibroblasts (HDFs)
that would overcome the obstacles the existing SKPC
isolation protocol faces.
In this study, we demonstrated that shikimic acid, a
major component of Sequoiadendron giganteum (SG)
callus extract, could induce mesenchymal-to-epithelial
transition (MET) and consequently convert human
fibroblast to neural precursor-like skin precursor cells
(NeuSKPCs). In addition, we identified that the receptor
for shikimic acid is the mannose receptor and that it in-
duced the major SKPC marker nestin through the
MYD88-P38 MAPK-CREB pathway. Finally, the results
of our artificial skin model and clinical study on aged fe-
male volunteers show that shikimic acid improves skin
regeneration.
Materials and methods
Cell culture and plant callus preparation
Human dermal fibroblasts (Gibco) were cultured in
high-glucose DMEM containing 10% fetal bovine serum,
L-glutamine, and penicillin/streptomycin (all from
Gibco).
Colony-forming assay (stained with crystal violet)
Cells were washed twice in ice-cold PBS and fixed with
ice-cold methanol for 10 min for permeabilization of
cells. Expanded colonies were stained by 0.1% crystal
violet (Sigma) and 10% ethanol in PBS solution for 5
min and PBS washed 4 times, and plate images were ac-
quired. For quantification, the colonies were incubated
with elution buffer (50% ethanol, 40% distilled water,
10% acetic acid) for 5 min and transferred to a 96-well
plate; the OD at 580 nm was determined using a micro-
plate reader.
Generation of NeuSKPCs and immunocytochemistry
To generate NeuSKPCs, HDFs were seeded on an ultra-
low attachment plate at 1.2 × 105 cells/ml density. The
composition of the NeuSKPCs media is DMEM:F12 (3:
1) supplemented with 2% B-27 supplement (all from
Gibco), 40 ng/ml basic fibroblast growth factor (R&D
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Biosystems), and 20 ng/ml EGF (Peprotech). The media
were changed, and shikimic acid was added every other
day.
For immunocytochemistry analysis, NeuSKPCs were
collected in a conical tube and centrifuged for segmenta-
tion. NeuSKPCs were prepared on slide glass. Primary
antibodies, anti-nestin (1:100, Sigma Aldrich), anti-
fibronectin (1:100, Santa Cruz Biotech), and anti-
vimentin (1:100, Santa Cruz Biotech), were diluted in
antibody diluent solution (Invitrogen) and incubated at
4 °C, overnight. Appropriate secondary antibodies (don-
key anti-rabbit Alexa Fluor 488 and anti-mouse Alexa
Fluor 555, 1:200) were used. The nucleus was stained
with DAPI (1:1000). Images were obtained using con-
focal microscopy (LSM 510 Meta, Carl Zeiss).
Reverse transcription and quantitative reverse
transcription PCR (qRT-PCR)
Total RNA was extracted using RNeasy mini kit (QIAG
EN), and cDNA was prepared with ReverTraAce qPCR
RT Master Mix (Toyobo). Quantitative reverse tran-
scription PCR was performed using FastStart SYBR
Green (Roche) and analyzed with Applied Biosystems
7500 Real-Time PCR System. Obtained data were nor-
malized to 18s rRNA and calculated into 2−ΔCt method.
Primers were listed in Table s1.
Western blot analysis
Total protein was isolated from cells with RIPA cell lysis
buffer (Thermo Fisher), supplemented with a complete
protease inhibitor cocktail (Genedepot) and 1mM DTT.
Lysates were incubated on ice for 30 min and vortexed
every 10 min. Protein concentration was determined by
BCA assay (Thermo Fisher). Proteins were separated on
8% gradient SDS-PAGE gels and transferred from gel
onto the polyvinyl difluoride (PVDF) membrane. The
membrane was blocked with 5% bovine serum albumin
(BSA) and incubated overnight at 4 °C with primary anti-
bodies. Detection was done using the Novex ECL HRP
Chemiluminescent substrate reagent kit (Invitrogen).
Western blot data were quantified by the ImageJ
software.
Microarray data acquisition and analysis
Hybridized microarrays were scanned using a DNA
microarray scanner and quantified with the Feature Ex-
traction Software (Agilent Technologies). All data
normalization and selection of genes with a specific fold
change were performed using human GE 4 X 44k (v2)
Array (Agilent Technologies). All numerical data were
normalized with intensity-dependent normalization
(LOWESS), where the ratio was reduced to the residual
of the Lowess fit of the intensity vs. ratio curve by using
GeneSpring 7.3. >2× fold changed genes were selected
and considered as differentially expressed genes (DEGs).
Functional annotation of analyzed genes was performed
according to the Gene Ontology Consortium. Gene clas-
sification was based on searches done using DAVID
(http://david.abcc.ncifcrf.gov/).
Tissue regeneration assay
The EpiDermFT-400 in vitro full-thickness skin tissue
model was purchased from MatTek Corporation (Ash-
land). The system consists of human-derived epidermal
keratinocytes (NHEK) and human-derived dermal fibro-
blasts (NHDF) which have been grown on a semiperme-
able membrane to form a multilayered, highly
differentiated model of the human dermis and epider-
mis. The tissues were cultured in a 6-well plate at 37 °C,
5% CO2 using a serum-free medium, according to the
manufacturer’s instruction. Upon arrival, 24 plugs were
immediately transferred to a 6-well plate with 2 ml EFT-
400 medium and incubated overnight at 37 °C, 5% CO2.
After overnight equilibration, the medium was replaced
with a pre-warmed fresh supply. The EpiDermFT-400
tissue was wounded by CO2 laser (100 mJ, 200 spots/
cm2, 300 μm spot diameter, eCO2 Mosaic Fractional
Laser, Lutronic Co., South Korea), cultured in ETF-400
culture media containing shikimic acid (2 mM, 20mM)
or control culture media for 4 days. After treatment,
EFT-400 tissues were fixed in 10% neutral-buffered for-
malin, embedded in paraffin, sectioned 8 mm thickness.
Clinical study design
Health adult volunteers who have wrinkle or sag on
inner arms (age > 50, n = 8) were recruited for the study
in the Chung-Ang University Hospital (Seoul, South
Korea). Prospective volunteers who had any systemic or
skin diseases or were using any medications for cosmetic
purposes in the last 1 month were excluded. Those who
had taken any systemic or topical medications 1 month
or 2 weeks prior to enrollment, respectively, were also
excluded. We randomly assigned the volunteers to one
of the following two groups (n = 4) by using double-
blind methods: SG callus 1.8% (shikimic acid; 36.25 mM)
complying cosmetic cream treated; vehicle cosmetic
cream treated. During the study period, the use of sys-
temic medications and topical agents, or washing of the
test sites, was prohibited. On the first day, 2 sites were
marked on the inner arms of volunteers, before applying
topical sample. The whole punch skin biopsy (3 mm in
diameter) was taken from the left inner arm, as a naive
normal control on the assumption that each inner arm’s
tissue histology is the same. The naive normal control
tissues obtained from the left inner arms were immedi-
ately embedded in optimal cutting temperature (OCT)
compound, frozen in liquid nitrogen, and stored at
−80 °C until the preparation of frozen sections or placed
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in 10% phosphate-buffered formalin. These naive normal
control tissues were used negative controls and were
stained concurrently to validate the staining procedure.
After the preliminary inspection, we applied creams
(0.2 ml) on each inner arm of volunteers by using an oc-
clusive patch for 3 weeks. After 3 weeks, the whole
punch skin biopsy (3 mm in diameter) was taken from
the right inner arm. The same tissue treatment process
was performed.
After all of the tissue samples (normal control tissues
and treated tissues) were obtained, skin specimens were
prepared for immunohistochemical staining at the same
time and imaged with the same settings. Five-micron
cryostat sections were cut on a cryostat microtome and
then fixed in acetone for 15 min. After three washes in
phosphate-buffered saline (PBS), the sections were incu-
bated in methanol with 0.3% hydrogen peroxide for 10
min to block the endogenous peroxidase activity. Non-
specific antibody binding was blocked by incubating the
sections with 10% normal donkey serum. Immunostain-
ing was performed for detecting stemness markers of
the epidermal layer by using anti-β1 integrin and anti-α6
integrin antibodies (Santa Cruz Biotech). The stained tis-
sue sections were photographed using a Zeiss micro-
scope (Axioskop 2), and images were obtained with a
digital camera (Olympus, Japan).
Statistical analysis
All experiments and groups were at least triplicates, and
all data were calculated as mean ± standard deviations
(SD). Group comparisons were performed by Student’s t
test when compared to two groups and AVOVA statistic
test when compared more than that. P values ≤0.01 were
considered as statistically significant values. All statistical
analyses were conducted using the GraphPad Prism
software.
Results
Shikimic acid from plant stem cell extract induces
dedifferentiation of human somatic cells
To investigate whether plant stem cell extract could re-
program somatic cells, we treated HDFs with SG callus
extract. Interestingly, the cell morphology changed after
7 days of treatment (Fig. 1a). This suggested that
mesenchymal-to-epithelial transition (MET) had oc-
curred, which is an early event in the reprogramming of
somatic fibroblasts into pluripotent stem cells. More-
over, after exposure to the extract, the HDFs showed in-
creased expression of stemness genes, such as OCT4,
NANOG, and Sox2 (Fig. 1b). These findings suggested
that the extract could reprogram human skin cells to an
undifferentiated state, such as multipotent precursor
cells. To identify the main active components of the SG
callus extract, we performed HPLC analysis and
identified three major compounds (Fig. 1c): shikimic
acid, caffeic acid, and trans-ferulic acid. Since there are
no previous reports on the reprogramming effects of any
of the compounds, we first aimed to compare each com-
pound’s potential to induce reprogramming. We treated
the HDFs with 5 μg/mL of each compound separately
and cultured them for 10 days. Only shikimic acid dis-
tinctly upregulated alkaline phosphatase (AP) activity
similar to SG callus extract (Fig. 1d, e), and significantly
increased colony formation by 4-folds (p < 0.001; Fig.
1f). On the other hand, caffeic and trans-ferulic acid
showed little reprogramming potency (Fig. 1d–f). How-
ever, while these data indicated that shikimic acid could
convert somatic cells into pluripotent cells, we could not
observe completely mature iPSCs after a single treat-
ment with it (Figure S1); thus, it can be said that shi-
kimic acid might act by increasing the level of stemness
of somatic cells.
Shikimic acid converted HDF spheres into neural
precursor-like skin precursor cells (NeuSKPCs)
To investigate whether nestin, the neural precursor cell
marker, is expressed in shikimic acid-treated HDF
spheres, we transfected HDFs with a nestin promoter-
GFP fusion vector as a reporter. GFP expression in-
creased depending on the dose of shikimic acid (1–10
mM). We found that the optimal concentration of shi-
kimic acid for enhancing nestin-GFP promoter activity
was 10 mM (Figure S2A). Figure 2a shows a scheme of
NeuSKPCs induction. The transfected HDFs were
seeded on an ultra-low attachment plate; spheres were
generated on day 3 and maintained for 3 weeks. GFP
was observed in shikimic acid-treated spheres from day
4 (Fig. 2b). Compared to the untreated spheres, shikimic
acid-treated spheres showed enhanced mRNA and pro-
tein expression of nestin, vimentin, and fibronectin,
which are known as SKPC markers. Interestingly, the ex-
pression of fibroblast-specific genes (Col1A1 and PDGF
Ra) were decreased (Fig. 2c, d). These data suggest that
shikimic acid converted fibroblasts into NeuSKPCs from
the early stage of sphere formation.
Characterization of shikimic acid-induced NeuSKPCs:
colony-forming ability and telomere elongation
The optimized time point for sphere maturation is 3
weeks. The shikimic acid-treated cells showed higher ex-
pression levels of nestin, fibronectin, and vimentin than
the untreated cells (Fig. 3a, Figure S3A).
To evaluate the self-renewal ability of NeuSKPCs, we
performed colony-forming assays. First, we dissociated
matured primary spheroids into single cells in order to
assess secondary sphere formation. The single cells were
seeded on ultra-low attachment plates to form secondary
spheres with or without shikimic acid treatment (Fig.
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3b). The treated group generated an approximately 2-
fold greater number of secondary spheres than the
untreated group. Interestingly, even after treating the
single cells that were not treated with shikimic acid
during the generation of primary spheres (UT-Treat),
the number of secondary spheres did not increase
(Fig. 3c, d). These data suggest that shikimic acid
could act by working on the early stage of induction
of NeuSKPCs.
To investigate the mechanism of how shikimic acid
could convert fibroblast to NeuSKPCs, we performed
global gene expression analysis, comparing human der-
mal fibroblast with or without shikimic acid. RNA sam-
ples were labeled with Cy3 (HDF) and Cy5 (shikimic
acid-treated HDF) then analyzed on Agilent human GE
4 X 44 k (v2) Array. Scatterplots demonstrated that shi-
kimic acid could change the global gene expression pat-





Fig. 1 SG-callus extract and its major component, shikimic acid, induce stemness in human fibroblast and expression of pluripotent stem cell
markers. a Bright-field images of HDF after treatment with SG callus extract (500 μg/ml) for 7 days. Scale bar = 500 μm. b RNA expression of
OCT4, NANOG, and Sox2 were analyzed by qRT-PCR. It was normalized to 18s RNA (N = 3 in each group, **p < 0.01). c HPLC chromatogram of
the SG-callus extract detected at the UV wavelength of 230 nm. The peak (RT = 4.248 min) is assigned to the shikimic acid. The peak (RT = 18.666
min) is assigned to the caffeic acid. The peak (RT = 21.672min) is assigned to the trans-ferulic acid. d A colony formation assay was performed on
naive HDF and HDF treated with SG-callus extract or shikimic acid, caffeic acid, and trans-ferulic acid at 10 days after treatment. Scale bar =
500 μm. Representative pictures are shown. e Relative stained colonies are quantified (N = 3 in each group, *p < 0.05, ***p < 0.001 compared
with the control)
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genes (DEGs) selected by a fold changes more than 2 re-
vealed that 6348 genes were differently expressed after shi-
kimic acid treatment (Figure S4A). Since the morphology
of HDF dramatically changed epitheloid by treatment of
shikimic acid (Figure S1B) and this mesenchymal-to-
epithelial transition (MET) phenomenon is one of the first
noticeable changes during reprogramming [13], we ana-
lyzed the genes regulating MET from the profile of DEGs.
Shikimic acid reduced the expression of mesenchymal cell
markers such as Twist, Zeb1, and Zeb2, while it increased
the expression of epithelial cell markers such as Claudin,
Occludin, CRB3, and E-cadherin (Figure S4B). We con-
firmed this gene expression pattern using qRT-PCR (Fig-
ure S4C). As we expected, MET-associated genes were
noticeably changed (Figure S4C). The other interesting
reprogramming-related gene is TERT. As it is reported
that telomeres are elongated during reprogramming [14],





Fig. 2 NeuSKPCs are induced by treatment of shikimic acid. a Scheme of generation of NeuSKPCs. b Morphology of NeuSKPCs. Nestin promoter
GFP was activated in the shikimic acid-treated groups (scale bar = 500 μm). c Western blot analysis was conducted using an anti-nestin antibody
(upper panel) in shikimic acid untreated or treated spheroids, and the quantified result is shown in the lower panel (*p < 0.05). d qRT-PCR
analysis of SKP-associated genes, nestin, fibronectin, vimentin, pluripotency-associated gene, Sox2, fibroblast-specific genes, Col1A1, and PDGFRa.
It was normalized to 18s RNA (N = 3 in each group, **p < 0.01, ***p < 0.001 compared with the control)





Fig. 3 (See legend on next page.)
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the telomere length. Indeed, TERT, a major component of
telomerase known to elongate telomeres of stem cells
[15], was highly expressed, and telomeres were elongated
after shikimic acid treatment (Fig. 3e, f).
NeuSKPCs induced by shikimic acid can differentiate into
the mesodermal and ectodermal lineage
The differentiation potential of SKPCs was reported to
be restricted to the mesodermal and ectodermal lineages
[9]. To evaluate whether the NeuSKPCs induced by shi-
kimic acid are multipotent, we induced their differenti-
ation into mesodermal and ectodermal lineage cells by
plating them onto a gelatin-coated dish in the presence
of adipogenic, osteogenic, and neuronal differentiation
media (Fig. 4a) [16]: their morphology changed depend-
ing on the media used. The cells were positive for Oil
Red O and von Kossa staining (Fig. 4b, c) and expressed
the adipocyte-specific markers C/EBPα, PPARγ, and
FABP (Fig. 4d) and osteocyte-specific markers RUNX2,
osteocalcin, and ALP (Fig. 4e). When nestin promoter-
GFP-positive spheres were attached to the plate, the cells
began to extend from the center of the sphere, and the
fluorescence of GFP was sustained. As differentiation
progressed, the nestin promoter became inactivated, and
no GFP expression was observed on differentiation day
2. As the cells differentiated into the neural cell lineage
(differentiation day 7), the nestin promoter was reacti-
vated and the GFP signal reappeared (Figure S5A, B).
The differentiated neural cells expressed MAP2, Tuj1,
NeuN, and NEUROD1 (Fig. 4f, g); these data corre-
sponded to the characteristics of SKPCs [9].
Shikimic acid-induced nestin expression via the MYD88/
MAPK/CREB signaling pathway
We investigated the molecular mechanism by which shi-
kimic acid induced the expression of nestin or converted
fibroblast to neural precursor cell. Shikimic acid report-
edly interacts with the cell surface mannose receptor
(MR) [17] and activates MYD88 through TLR2 [18].
Downstream of MYD88, the signaling diverges into three
MAPK pathways, MAPK-Kinase (MKK)1/2, MKK3/6,
and MKK7 [19]. MKK1/2 regulates ERK1/2 activity,
while MKK3/6 and MKK7 regulate the phosphorylation
of P38 MAPKs and JNK, respectively [20, 21]. We thus
investigated the phosphorylation of these molecules after
shikimic acid treatment. After 15 min of shikimic acid
treatment, MKK3/6, P38, and CREB were phosphory-
lated (Fig. 5a). On the other hand, there was no change
in the phosphorylation level of MKK1/2, and phospho-
ERK1/2 was downregulated. There was no significant
change in the phosphorylation levels of MKK7 and JNK
(Figure S6). These data suggested that shikimic acid acti-
vates MKK3/6 phosphorylation, which led to the phos-
phorylation of downstream signals, including P38
MAPKs and CREB. To confirm whether MYD88 and
P38 are required for the induction of nestin by shikimic
acid, we assessed nestin expression following the
addition of signal inhibitors to the culture medium.
HDFs were seeded on ultra-low attachment plates and
maintained for 4 days with or without shikimic acid, and
the concentration of the inhibitors was optimized (Fig-
ure S7). After treatment with the MYD88 inhibitor
ST2825, nestin expression considerably decreased (Fig.
5b, Figure S8A). The inhibitor of P38 MAPK activity,
SB203580, inhibited shikimic acid-induced nestin ex-
pression (Fig. 5c, Figure S8B). On the other hand, the
JNK inhibitor, SP600125, did not affect nestin expression
(data not shown). Therefore, our results indicated that
shikimic acid specifically activated the MYD88-MKK3/6
signaling axis, which phosphorylated P38 MAPKs and
CREB. To investigate whether the transcription factor
CREB binds to the nestin promoter, we performed ChIP
assays and found that the nestin promoter recruited
CREB (Fig. 5d). After shikimic acid treatment, the bind-
ing of CREB increased 2-fold compared with the un-
treated control, indicating that CREB bound directly to
the nestin promoter and increased the expression of nes-
tin after shikimic acid treatment.
Shikimic acid or plant callus extracts enhanced human
skin regeneration in the artificial skin model and in the
clinical study with healthy volunteers
To test the effect of shikimic acid on skin regeneration,
we used two different models, such as ex vivo human
skin equivalent tissue model and in vivo clinical study
with female volunteers. Firstly, we prepared a wounded
skin equivalent tissue model and treated it with 2 or 20
mM shikimic acid. Since we used a fixed laser parameter
of 100 mJ, 200 spots/cm2 300 μm spot diameter to
wound the skin, it was presumed that the injury sizes of
all skin equivalent tissue models were the same at the
baseline. Two days after inducing the wound using a
(See figure on previous page.)
Fig. 3 Characterization of shikimic acid-induced NeuSKPCs. a Immunofluorescence of SKP markers including anti-nestin (green), anti-fibronectin,
and anti-vimentin (red) in shikimic acid-induced NeuSKP on day 21. DAPI was used to identify the nucleus of the cells (scale bar = 50 μm). b
Scheme of colony-forming assay (secondary sphere formation). c Bright-field images of secondary NeuSKPCs with or without shikimic acid for 4
days (scale bar = 500 μm). d The number of secondary spheres from matured NeuSKPCs (N = 5 in each group, *p < 0.05, ***p < 0.001). e qRT-PCR
analysis of TERT in matured NeuSKPCs (10 mM shikimic acid was treated for 21 days, **p < 0.01 compared with the untreated control). f
Comparison of the average telomere length ration between shikimic acid untreated or treated (**p < 0.01 compared with the untreated control)
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CO2 laser, the epidermal and dermal parts were repaired
in shikimic acid-treated skin, but not in the untreated
control. Four days after wound induction, complete re-
epithelialization and restoration of the dermis occurred
in the shikimic acid-treated tissue, but not in the un-
treated control. Specifically, the collagen structure in the
dermal layer became denser in the treated skin than in
the untreated control (Fig. 6a). Secondly, to investigate
the dermal reconstruction potential of shikimic acid, we
prepared a dermal equivalent that contained human epi-
dermal neonatal keratinocytes on the dermal layer and
human dermal fibroblasts under the dermal layer and
treated it with shikimic acid. The treatment significantly
increased the proliferation of keratinocytes compared
with the control, and this effect was abolished by
MYD88 inhibitor treatment (Fig. 6b, c). These data sug-
gest that, via the MYD88 pathway, shikimic acid can
stimulate fibroblasts under the dermal layer to secrete
cytokines, leading to the proliferation of keratinocytes.
Finally, to confirm in healthy female volunteers
whether the SG callus extract containing shikimic acid
could increase skin tissue stemness markers and en-
hance the composition of the extracellular matrix of hu-







Fig. 4 Shikimic acid-induced NeuSKPCs can differentiate into ectodermal and mesodermal lineage. a Scheme of differentiation for NeuSKPCs. b
Lipid drops of adipogenic differentiated cells were stained by Oil red O (upper panel, scale bar = 100 μm). c Accumulated calcium of
osteogenically differentiated cells were stained by von Kossa staining (scale bar = 200 μm). d qRT-PCR analysis of adipocyte-specific genes, CEBP,
PPAR, and FABP (N = 3 in each group; ns, not significant, *p < 0.05, **p < 0.01). e qRT-PCR analysis of osteocyte-specific genes, Runx2,
osteopontin, and ALP (N = 3 in each group, *p < 0.05, **p < 0.01). f Differentiated neural cells were stained with MAP2 (green), Tuj1(red), and
NeuN (magenta) (scale bar = 100 μm). g qRT-PCR analysis of neuron-specific genes, Tuj1, and NeuroD1 (N = 3 in each group, **p < 0.01)
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female volunteers, aged over 50 years (n = 8). The 1.8%
SG callus cream (36.25 mM shikimic acid) or vehicle
cream was applied topically using occlusive patches for
3 weeks. Two representative immuno-histologic images
were prepared from the biopsied skin tissue of the inner
arms of the treated patients (vehicle cream-treated skin
vs 1.8% SG callus cream-treated skin). In hematoxylin
and eosin staining, all samples showed an upper strati-
fied squamous epithelium, a dense, fine fibrous dermis,
and a basement membrane between the epidermis and
dermis. There was no significant change in epidermal
morphology (Fig. 6d). In the SG callus-treated skin, how-
ever, the expression of skin and neural stem cell markers
(β1 and α6 integrin) were increased in the epidermal
basal layer, and the procollagen expression level was in-
creased in the dermis compared to the vehicle cosmetic
cream treated skin (Fig. 6d, e). These data demonstrate
that shikimic acid enhances skin remodeling by inducing
stemness markers and enhancing the composition of the
extracellular matrix of the skin.
Discussion
Plant stem cells extract converts human fibroblast to skin
precursor cells
In plants, nuclear reprogramming occurs without manipula-
tion of the nuclear status by external triggers [4, 22]. We pre-
dicted that plant stem cells, which possess the ability to
convert mature somatic cells to immature blastemal cells in
plants [23], might have the capacity to reverse the fate of hu-
man somatic cells. Indeed, after 10 days of callus extract
treatment, the HDFs in our study changed morphologically,
resembling epithelial cells (Figure S1), and expressed stem-
ness markers including Oct4, Sox2, Klf4, and Nanog (Fig. 1b
and Figure S9). However, we could not observe completely
mature iPSCs after a single treatment with it (Fig. 1a). This
mechanism remained to be investigated, but we know that
one of the major iPSC generating factors, c-Myc, was not in-
duced by callus extract. Since C-Myc was a very important
boosting factor during iPSC generation, we assumed that a





Fig. 5 Shikimic activates nestin expression via the MyD88/p38/CREB signaling pathway. a After the designated incubation time with shikimic acid,
the phosphorylation level of MAPK-kinase (MKK)3/6, p38 MAPK, and CREB was determined (upper). Quantification of the obtained results (N = 3 in
each group, *p < 0.05, **p < 0.01, ***p < 0.001 compared with the control) (lower). b Western blot analysis of nestin, fibronectin, and vimentin
after treatment of MyD88 inhibitor and shikimic acid. c Western blot analysis of nestin, fibronectin, and vimentin after treatment of p38 inhibitor
and shikimic acid. d Chromatin immunoprecipitation (ChIP) assay on the promoter of nestin. Phosphor-CREB antibody was used for the ChIP
assay (N = 3 in each group, *p < 0.05)
Kwon et al. Stem Cell Research & Therapy          (2021) 12:346 Page 10 of 13
We demonstrated that, of the three major compounds
of the callus extract, shikimic acid was the one that
could induce reprogramming. We then investigated
whether the reprogrammed cells could differentiate into
different types of cells and whether they possessed self-
renewal capacity. Although a single treatment with shi-
kimic acid failed to generate complete iPSCs (Figure
S1B), it did induce transition into SKPCs that exhibited
stemness and could differentiate into the mesodermal
and ectodermal lineage (Fig. 4). These results suggest
that a single molecule could convert somatic cells into
NeuSKPCs. In addition, we confirmed the self-renewal
ability of NeuSKPCs: single cells originating from disso-
ciated NeuSKPCs could generate secondary spheres, and
shikimic acid-treated cells could generate an increased
number of spheres expressing markers of NeuSKPCs
(Fig. 3a–c). Moreover, the self-renewal ability of shikimic
acid affected telomeres by increasing the expression of
TERT, leading to telomere elongation (Fig. 3d–f). These
data suggest that shikimic acid can convert somatic to
precursor cells.
Shikimic acid acts through the mannose receptor and the
MYD88/P38/CREB signaling pathway
Shikimic acid is an important intermediate in the bio-
synthesis of lignin and most alkaloids of plants. It has
been found in many organs, such as stems, leaves, and
fruits, in a variety of plants [24]. Industrially, it is gener-
ally utilized as a starting material for the synthesis of
oseltamivir, a drug against the influenza virus [25]. Al-
though there are numerous reports about chemical and
pharmaceutical applications of shikimic acid, this is the





Fig. 6 Shikimic acid facilitates wound healing and enhances dermal reconstruction in the artificial human skin ex-vivo model. a Representative
fluorescent immuno-histologic staining of cytokeratin (green) in the epidermis and cell nucleus (blue) in the basement membrane and collagen
(red) in the dermis from human skin equivalent tissue. Tissue was frozen in OCT and stained by the immunofluorescence method. Data are
representative of N = 3. Scale bar = 10 μm. b The dermal layers were seeded with 3 different fibroblasts: Non-treated fibroblast (control),
fibroblast treated with shikimic acid, or fibroblast treated with shikimic acid plus MyD88 inhibitor. Keratinocytes were seeded over the dermal
layer. This skin equivalent was cultured in the air-liquid interface for 8 days. On 8 days, the paraffin sections were stained for hematoxylin and
eosin (scale bar = 50 μm). c The quantification of epidermal thickness (N = 3 in each group compared with control HDF, p < 0.001 or p < 0.007).
d SG-callus extract (36.25 mM shikimic acid) increased the expression level of β1 integrin and α6 integrin that are stem cell markers at the basal
layer of the epidermis. It also increased collagen amounts in the dermis (brown color in immunostaining) (scale bar = 100 μm). e N = 8, treated
group compared with vehicle cream treated group, ***p < 0.001. ED, epidermis; D, dermis
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We elucidated the biological mechanism of shikimic
acid-driven cell fate conversion, namely, shikimic acid is
known to interact with C-type lectin-like domains
(CTLD) of the mannose receptor, which leads to subse-
quent activation of the MYD88 signaling pathway. The
mannose receptor selectively recognizes mannose, N-
acetyl glucosamine, and fructose residues. Thus, shikimic
acid could act as a mimic of these carbohydrates [16].
The other major components of the SG callus extract,
caffeic acid and trans-ferulic acid, are not recognized by
the mannose receptor, making shikimic acid the only SG
callus compound that can induce reprogramming. In
particular, shikimic acid activates the MKK3/6-P38
MAPK-CREB pathway, which activates the promoter of
nestin (Fig. 5). Since nestin is a key molecule in SKPC
generation, increasing its expression is an important
event in reprogramming. In fact, MYD88 downstream
signaling molecules JNK, P38, and ERK are known to
affect reprogramming [19, 26, 27]. Among these, shi-
kimic acid specifically activated the P38-CREB signaling
axis via the phosphorylation of MKK3/6. Moreover, we
confirmed that a CREB-biding sequence exists in the
nestin promoter (Fig. 5d). Furthermore, a CREB-binding
sequence was also found in the fibronectin and vimentin
promoters, so there is a possibility that they share the
MKK3/6–P38–CREB signaling with nestin. However, fu-
ture studies should precisely determine the activation
mechanism of fibronectin and vimentin.
Shikimic acid enhances human skin regeneration
Human skin equivalents are bioengineered substitutes
composed of primary human skin cells (keratinocytes, fi-
broblasts, and/or stem cells) and extracellular matrix
components (mainly collagen). They are commercially
used as clinical skin substitutes and as models for per-
meation and toxicity screening. In this study, we used
such a model to test whether shikimic acid could en-
hance skin regeneration. We observed complete repair
of the dermis after treatment with shikimic acid.
Complete re-epithelialization and restoration of the der-
mis were observed, accompanied with a denser collagen
structure (Fig. 6a). According to these results, shikimic
acid not only affects dermal fibroblast fate by increasing
the level of stemness, but also improves wound healing.
Moreover, we clinically tested the topical application
of the SG callus extract and found that the levels of
beta1 and alpha6 integrin and procollagen were in-
creased in the treated dermis (Fig. 6d). Beta1 integrin
has been known as a major molecule to regulate neural
stem cell (NSC) growth factor responsiveness. It may
provide NSC with the capacity to react to a dynamic
“niche” and to respond adequately by either remaining
as stem cells [28]. Integrin alpha6 are also broadly
expressed among different types of stem cells and play
an important role in maintaining self-renewal of stem
cells [29]. Since integrin-linked kinase (ILK) regulates
the niche of epidermal stem cell in hair follicle [30], shi-
kimic acid-induced integrin may affect hair regeneration.
These data demonstrated that shikimic acid can en-
hance skin remodeling by inducing a “niche” of stem
cells in the skin. Therefore, we expect that shikimic acid
can be used as a novel material in skin regeneration bio-
therapeutics or cosmetics. Although we have shown the
potential effect of shikimic acid-containing cosmetic
cream in this preliminary clinical study, the ability of the
active ingredient in penetrating the epidermal barrier
must be investigated to be used in cosmetics. Therefore,
based on the results of this study, further studies are
needed to investigate how and how much of the active
ingredient crosses the epidermal barrier in vivo in order
to exert a substantial effect on the dermis. Last but not
least, we also anticipate that the efficiency of iPSC gen-
eration can be improved by simultaneous treatment with
Yamanaka factors and shikimic acid since it was able to
induce MET, cell proliferation, self-renewal, and stem-
ness markers, which are essential factors of cell
reprogramming.
In conclusion, by demonstrating that shikimic acid, a
major chemical compound of plant callus, could induce
fate conversion from a somatic cell to a skin precursor
cell. We believe that our study made a considerable con-
tribution in the field of reprogramming by discovering a
novel compound that could induce the reprogramming
process on human somatic cells.
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